Premium
Are vitiligo treatments cost‐effective? A systematic review
Author(s) -
McManus E.,
Sach T.,
Levell N.J.
Publication year - 2018
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15881
Subject(s) - vitiligo , depigmentation , dermatology , medicine , calcineurin , pimecrolimus , camouflage , pigmentation disorder , surgery , biology , transplantation , zoology
Vitiligo is characterised by well demarcated, cutaneous, macular depigmentation, with worldwide prevalence estimated to be between 0.2-1.8% [1]. Vitiligo treatments aim to encourage re-pigmentation and include topical corticosteroids, calcineurin inhibitors and NB-UVB phototherapy. Camouflage can also be prescribed to help mask the appearance of vitiligo, although this is frequently only prescribed for the face